Martine Rothblatt - Chairman & CEO, United Therapeutics Corp

As of March 16, 2021


Martine Rothblatt Net Worth

  • Net worth is estimated to be at least $470.32M
  • Owns at least 664,019 units of United Therapeutics Corp stock
  • Sold an estimated value of $473.6M in the last 18 years at United Therapeutics Corp

Martine Rothblatt Trading

  • Largest purchase of shares was 39,014 units , worth over $3.32M on June 11, 2009
  • Largest sale of shares was 50,000 units , worth over $6.23M on September 16, 2014
  • In total has made about 770 transactions over 18 years
  • Usually trades in December, with the busiest year in 2015
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

United Therapeutics Corp Insider Trading

  • The most recent transaction was 6,000 units sold on September 16, 2021 by Paul Mahon worth over $1.22M
  • In the last 18 years, insiders at United Therapeutics Corp sold an estimated value of $1.24B and bought an estimated value of $452.33M
  • The most active traders are Martine Rothblatt, Chairman & CEO,  Roger Jeffs,  and Paul Mahon, EVP & General Counsel
  • Insider trading is most common in June, with the busiest year in 2015

UNITED THERAPEUTICS Corp Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1